Sjs Investment Consulting Inc. Bristol Myers Squibb CO Transaction History
Sjs Investment Consulting Inc.
- $534 Million
- Q3 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 1,005 shares of BMY stock, worth $54,983. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,005
Previous 830
21.08%
Holding current value
$54,983
Previous $34,000
52.94%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding BMY
# of Institutions
2,468Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.2 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.68 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.26 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.23 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $116B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...